About Achaogen :
Our vision is to change the way people think about the discovery and development of new drugs for the treatment of serious multi-drug-resistant infections. According to the Centers for Disease Control and Prevention (CDC), at least 2 million people become infected with antibiotic-resistant bacteria each year in the United States, and 23,000 people die annually because of these infections. By 2050 antimicrobial resistance is projected to result in ~10 million deaths per year. Furthermore, the need for new antibiotics to treat carbapenem-resistant-Enterobacteriaceae (CRE) is particularly acute, and in 2013, the CDC labeled CRE as “nightmare bacteria” and indicated that CRE pose a public health threat requiring “urgent and aggressive action.”
Achaogen is developing plazomicin, our lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including CRE. Our second product candidate is C-Scape, an orally-administered beta-lactam/beta-lactamase inhibitor combination.
In addition to our deep expertise in infectious diseases and antibiotic drug discovery, we have established a state of the art antibody discovery platform that enables us to opportunistically expand outside of infectious diseases and tackle additional therapeutic areas with tremendous patient need. Having both small molecule and antibody drug discovery development capabilities gives us the opportunity to tackle the most compelling targets with the most appropriate drug modality.
Intrinsic to our five key core values of integrity, accountability, transparency, scientific rigor, and drive, Achaogen is committed to addressing such public health crisis affecting millions globally. With a focused strategy that leverages the passion and talent of our scientists, we have established specialized research and development capabilities in antimicrobial research and drug discovery.
At a Glance
We seek an inspired leader to chart the future of the Assay Development and Screening (ADSC) group at Achaogen, a multidisciplinary team that touches all aspects of our research organization.
About You - What You’ll Do
In collaboration with all research departments, develop a 3-year roadmap of assays, workflows and infrastructure to support the growing discovery pipeline needs and to ensure that the most promising drugs transition from research to early development
About You - What You’ll Need
About the Team